Pharmaceutical group · India
Aurobindo Pharma
A group of 16 companies with 1,509 medicines in 8 countries.
Group structure
16 companies in 9 countries
Loading your page…
Loading your page…
Pharmaceutical group · India
A group of 16 companies with 1,509 medicines in 8 countries.
16 companies in 9 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 1,509
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABACAVIR E LAMIVUDINA AUROBINDOCompressa rivestita con film | Lamivudine, Abacavir | Italy | Authorised | |
| Abacavir/Lamivudine Aurobindo 600/300 mg, filmomhulde tablettenFilmomhulde tablet | Abacavir, Lamivudine | Netherlands | Authorised | 2017 |
| ABACAVIR SULFATE AND LAMIVUDINE600mg base; 300mg · Tablet | Abacavir, Lamivudine | United States | Marketed | 2016 |
| ACARBOSIO AUROBINDOCompressa | Acarbose | Italy | Authorised | |
| Acebutolol Aurobindo 200 mg, filmomhulde tablettenFilmomhulde tablet | Acebutolol | Netherlands | Authorised | 2018 |
| Acebutolol Aurobindo 400 mg, filmomhulde tablettenFilmomhulde tablet | Acebutolol | Netherlands | Authorised | 2018 |
| Acenocoumarol Aurobindo 1 mg, tablettenTablet | Acenocoumarol | Netherlands | Authorised | 2022 |
| ACETILCISTEINA AUROBINDO ITALIAGranulato per soluzione orale in bustina | Acetylcysteine | Italy | Authorised | |
| Acetylcysteïne Auro 200 mg, bruistablettenBruistablet | Acetylcysteine | Netherlands | Authorised | 2022 |
| Acetylcysteïne Auro 600 mg, bruistablettenBruistablet | Acetylcysteine | Netherlands | Authorised | 2022 |
| Acetylcysteïne hoesttabletten bruis Sanias 200 mg, bruistablettenBruistablet | Acetylcysteine | Netherlands | Authorised | 2012 |
| Acetylcysteïne hoesttabletten bruis Sanias 600 mg, bruistablettenBruistablet | Acetylcysteine | Netherlands | Authorised | 2016 |
| Acetylcysteïne hoesttabletten bruis Sanias 600 mg, bruistablettenBruistablet | Acetylcysteine | Netherlands | Authorised | 2012 |
| Acetylcysteïne Sanias 200 mg, poeder in sachetsPoeder voor oraal gebruik | Acetylcysteine | Netherlands | Authorised | 1992 |
| Acetylcysteïne Sanias 600 mg, bruistablettenBruistablet | Acetylcysteine | Netherlands | Authorised | 2016 |
| Acetylcysteïne Sanias 600 mg, poeder in sachetsPoeder voor oraal gebruik | Acetylcysteine | Netherlands | Authorised | 1995 |
| Acetylsalicylzuur Aurobindo cardio 80 mg, tablettenTablet | Acetylsalicylzuur | Netherlands | Authorised | 2002 |
| Acetylsalicylzuur Cardio Aurobindo 80 mg, dispergeerbare tablettenDispergeerbare tablet | Acetylsalicylzuur | Netherlands | Authorised | 2008 |
| ACICLOVIR AUROBINDOCrema | Aciclovir | Italy | Authorised | |
| Aciclovir Aurobindo 200 mg, tablettenTablet | Aciclovir | Netherlands | Authorised | 2019 |
| Aciclovir Aurobindo 400 mg, tablettenTablet | Aciclovir | Netherlands | Authorised | 2019 |
| Aciclovir Aurobindo 800 mg, tablettenTablet | Aciclovir | Netherlands | Authorised | 2019 |
| ACICLOVIR AUROBINDO ITALIACrema | Aciclovir | Italy | Authorised | |
| ACICLOVIR AUROBINDO PHARMACompressa | Aciclovir | Italy | Authorised | |
| ACIDO ACETILSALICILICO AUROBINDOCompressa gastroresistente | Acetylsalicylic acid | Italy | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 710 | 710 | 0 | CompaniesAll medicines |
| Italy | 239 | 239 | 0 | CompaniesAll medicines |
| Romania | 219 | 0 | 219 | CompaniesAll medicines |
| Spain | 142 | 0 | 142 | CompaniesAll medicines |
| United States | 106 | 93 | 13 | CompaniesAll medicines |
| Brazil | 63 | 37 | 26 | CompaniesAll medicines |
| Saudi Arabia | 25 | 25 | 0 | CompaniesAll medicines |
| Canada | 5 | 5 | 0 | CompaniesAll medicines |
Also in the registers of Singapore, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence